T. Nawata, N. Takahashi and T. Oopie, “Cardioprotection by streptozotocin-induced diabetes and insulin against ischemia/reperfusion injury in rats,” J. Cardiovasc. Pharmacol., 2002, Vol. 40, No. 4, pp. 491-500.
 H. Chen, W.L. Shen and X. H. Wang, “Paradoxically enhanced heart tolerance to ischemia in type I diabetes and role of increased osmolarity,” Clin. Exp. Pharmacol. Physiol., 2006, Vol. 33, No. 10, pp. 910-916.
 T. A. Dubiley, T. A. Badova, S. A. Migovan and Yu. E. Rushkevich, “Influence of ischemia/reperfusion on function of isolated heart in rats of different ages with streptozotocin diabetes” Problems of Ageing and Longevity, 2007, Vol. 16 No. 1, pp. 11-21.
 S. A. Afanas'ev, D. S. Kondratieva, L. P. Tsapko, S. V. Popov and R. S. Karpov, “Features inotropic responses of rat myocardium at extrasystolic effect in the combined development of infarction atherosclerosis and diabetes mellitus,” Vestnik Arrhythmology, 2009, Vol. 55, pp. 56-59.
 M. V. Egorova, S. A. Afanas’ev, S. V. Popov and R. S. Karpov, “Adaptive changes at combined development of postinfarction remodeling and diabetes,” Bulletin of Experimental Biology and Medicine, 2010, Vol. 150, No. 8, pp. 132-135.
 D. S. Kondratieva, S. A. Afanas’ev, L. P. Falaleeva and V. P. Shakhov, “Inotropic response of myocardium of rats with postinfarction cardiosclerosis on extrasystolic effect,” Bulletin of Experimental Biology and Medicine, 2005, Vol. 139, No. 6, pp. 613-616.
 E. N. Mokhova and L. S. Haylova, “Involvement of anion carriers of the inner membrane of mitochondria in the uncoupling action of fatty acids,” Biochemistry (Moscow), 2005, Vol. 70, No. 2, pp. 197-202.
 S. N. Molchanov, S. A. Lyusov, A. V. Govorin and I. V. Neverov, “Serum lipids at various stages and morphofunctional types of heart failure in patients with myocardial infarction,” Russian Cardiology Journal, 2005, No. 2, pp. 18-25.
 M. V. Egorova, S. A. Afanas’ev and S. V. Popov, “The role of phospholipase A2 in the activation of respiration of isolated cardiomyocytes with infarction cardiosclerosis,” Bulletin of Experimental Biology and Medicine, 2008, Vol. 146, No. 12, pp. 631-633.
 “The sequence of events during the development of non-specific cell responses to injury,” In: V. V. Novitsky, E. D. Goldberg, O. I. Urazova Eds., Pathophysiology, Publ. GEOTAR-Media, Moscow, 2010, Vol. 1, pp. 59-62.
 L. D. Lukyanova, “Mitochondrial dysfunction - a typical pathological process, the molecular mechanism of hypoxia,” In: L. D. Lukyanova and I. B. Ushakov, Eds., Problems of hypoxia: molecular, physiological and medical aspects, Publ. “Origins”, Moscow, 2004. pp. 8-18.
 E. I. Maevsky, E. V. Grishina, A. S. Rosenfeld, A. M. Zyakun, M. N. Kondrashova and V. M. Vereshchagina, “Anaerobic formation of succinate and facilitating its oxidation - the possible mechanisms of cell adaptation to hypoxia,” Biophysics, 2000, Vol. 45, No. 3, pp. 509-513.
 C. G. M. Millar, G. F. Baxter and C. Thiemermann, “Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implications,” Pharmacol. Ther., 1996, Vol. 69, pp. 143-151.
 D. M. Yellon and G. F. Baxter, “A “second window of protection” or delayed preconditioning phenomenon: future horizons for myocardial protection?,” J. Mol. Cell. Cardiol. Medikography, 1995, Vol. 27, pp. 1023-1034.